Reprint

Outcomes and Therapeutic Management of Bladder Cancer

Edited by
September 2020
120 pages
  • ISBN978-3-03936-934-8 (Hardback)
  • ISBN978-3-03936-935-5 (PDF)

This is a Reprint of the Special Issue Outcomes and Therapeutic Management of Bladder Cancer that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary
Bladder cancer is the second most common genitourinary malignancy, with 81,190 estimated new diagnoses in 2018, in the United States alone. Transurethral resection of the bladder and radical cystectomy with bilateral pelvic lymph node dissection constitute the standard treatment for non-muscle invasive or very high-risk non-muscle invasive bladder cancer, respectively. However, survival expectations have not shown to improve in the last 20 years, and new diagnostic and therapeutic tools are urgently needed to improve the outcomes of this potentially lethal disease.

Related Books

August 2020

Nutrition for Anemia

Medicine & Pharmacology
September 2023

Urothelial Carcinoma: Clinical Diagnosis and Treatment

Medicine & Pharmacology
May 2022

Urological Cancer 2021

Medicine & Pharmacology
March 2023

Urological Cancer 2022

Biology & Life Sciences
...